{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:42:13Z","timestamp":1785228133215,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023375","name":"The Hilary Craft Charitable Foundation Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.meddos.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:49:21Z","timestamp":1739465361000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessing proton plans with 3 different beam lines vs photon plans for early-stage lung cancer"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-7847","authenticated-orcid":false,"given":"Tara","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Kolano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Donaghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Stephans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Videtic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2017.10.037","article-title":"Tumor control and toxicity for common stereotactic body radiation therapy dose-fractionation regimens in stage I non-small cell lung cancer","volume":"100","author":"Stephans","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.meddos.2025.01.006_bib0002","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.ijrobp.2021.07.647","article-title":"Limited toxicity of hypofractionated intensity modulated radiation therapy (H-IMRT) for head and neck cancer","volume":"111","author":"Mayo","year":"2021","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"4","key":"10.1016\/j.meddos.2025.01.006_bib0003","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3857\/roj.2019.00633","article-title":"Current status of proton therapy techniques for lung cancer","volume":"37","author":"Han","year":"2019","journal-title":"Radiat Oncol J"},{"issue":"5","key":"10.1016\/j.meddos.2025.01.006_bib0004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5732\/cjc.010.10529","article-title":"Proton therapy in clinical practice","volume":"30","author":"Liu","year":"2011","journal-title":"Chin J Cancer"},{"issue":"4","key":"10.1016\/j.meddos.2025.01.006_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.21037\/cco.2016.07.03","article-title":"Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer","volume":"5","author":"McKeever","year":"2016","journal-title":"Chinese Clin Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0006","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jamaoncol.2019.4889","article-title":"Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer","volume":"6","author":"Baumann","year":"2020","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.meddos.2025.01.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.41538","article-title":"Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy","volume":"5","author":"Youssef","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.meddos.2025.01.006_bib0008","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtho.2020.10.013","article-title":"Toxicity and survival after intensity-modulated proton therapy (IMPT) versus passive scattering proton therapy (PSPT) for non-small cell lung cancer","volume":"16","author":"Gjyshi","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0009","doi-asserted-by":"crossref","first-page":"199","DOI":"10.21037\/tlcr.2018.04.12","article-title":"Proton therapy for early-stage non-small cell lung cancer (NSCLC)","volume":"7","author":"Gomez","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.meddos.2025.01.006_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cllc.2014.12.001","article-title":"Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study","volume":"16","author":"Kesarwala","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.meddos.2025.01.006_bib0011","series-title":"Principles and practice of proton beam therapy","first-page":"231","article-title":"Chapter 26: monitor unit (MU) calculation","author":"Zhu","year":"2015"},{"key":"10.1016\/j.meddos.2025.01.006_bib0012","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2018.11.015","article-title":"Intensity modulated proton therapy (IMPT) - the future of IMRT for head and neck cancer","volume":"88","author":"Moreno","year":"2019","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.meddos.2025.01.006_bib0013","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2006.01.052","article-title":"Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non\u2013small-cell lung cancer","volume":"65","author":"Chang","year":"2006","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"13","key":"10.1016\/j.meddos.2025.01.006_bib0014","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1016\/S1470-2045(14)70345-6","article-title":"High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer","volume":"15","author":"De Ruysscher","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.meddos.2025.01.006_bib0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/acm2.12459","article-title":"Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: a dosimetric comparative study","volume":"19","author":"Liu","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"8","key":"10.1016\/j.meddos.2025.01.006_bib0016","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/j.cllc.2022.07.017","article-title":"Cardiopulmonary toxicity following intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for stage III non-small cell lung cancer","volume":"23","author":"Yu","year":"2022","journal-title":"Clinical Lung Cancer"},{"issue":"9","key":"10.1016\/j.meddos.2025.01.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1118\/1.4837155","article-title":"A dynamic collimation system for penumbra reduction in spot-scanning proton therapy: proof of concept","volume":"41","author":"Hyer","year":"2014","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.meddos.2025.01.006_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acm2.12231","article-title":"Evaluation of dosimetric advantages of using patient-specific aperture system with intensity-modulated proton therapy for the shallow depth tumor","volume":"19","author":"Yasui","year":"2018","journal-title":"J Appl Clin Med Phys"},{"issue":"11","key":"10.1016\/j.meddos.2025.01.006_bib0019","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1002\/mp.13193","article-title":"New horizons in particle therapy systems","volume":"45","author":"Farr","year":"2018","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.meddos.2025.01.006_bib0020","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/j.ijrobp.2020.07.2334","article-title":"Proton LINAC transverse beam scanning performance implications for therapeutic quality improvement","volume":"108","author":"Farr","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.meddos.2025.01.006_bib0021","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1002\/mp.15659","article-title":"Ultra-high dose rate radiation production and delivery systems intended for FLASH","volume":"49","author":"Farr","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.meddos.2025.01.006_bib0022","unstructured":"Inc. R.L. Raystation 10B User Manual. 2020:17-1167. Accessed April 04, 2024. https:\/\/www.raysearchlabs.com\/siteassets\/raystation-landing-page\/safety-and-performance-rs\/2020-12-17-raystation-10b-instructions-for-use.pdf."},{"issue":"1","key":"10.1016\/j.meddos.2025.01.006_bib0023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.meddos.2023.10.009","article-title":"Treatment planning of scanned proton beams in RayStation","volume":"49","author":"Janson","year":"2023","journal-title":"Medical Dosimetry"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0024","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2017.11.005","article-title":"Robust proton treatment planning: pphysical and biological optimization","volume":"28","author":"Unkelbach","year":"2018","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.meddos.2025.01.006_bib0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.adro.2020.03.001","article-title":"Scanning Beam proton Therapy versus Photon IMRT for stage III lung cancer: ccomparison of dosimetry, toxicity, and outcomes","volume":"5","author":"Zou","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.meddos.2025.01.006_bib0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13014-017-0866-0","article-title":"Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy","volume":"12","author":"Chi","year":"2017","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0027","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijrobp.2013.01.024","article-title":"Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer","volume":"86","author":"Grassberger","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0028","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2018.02.009","article-title":"Impact of spot size and spacing on the quality of robustly optimized intensity modulated proton therapy plans for lung cancer","volume":"101","author":"Liu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.meddos.2025.01.006_bib0029","doi-asserted-by":"crossref","first-page":"e13512","DOI":"10.1002\/acm2.13512","article-title":"Small spot size versus large spot size: eeffect on plan quality for lung cancer in pencil beam scanning proton therapy","volume":"23","author":"Rana","year":"2022","journal-title":"J Appl Clinical Med Phys"},{"key":"10.1016\/j.meddos.2025.01.006_bib0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejmp.2018.12.011","article-title":"Impact of spot size variations on dose in scanned proton beam therapy","volume":"57","author":"Kraan","year":"2019","journal-title":"Phys Med."},{"issue":"1","key":"10.1016\/j.meddos.2025.01.006_bib0031","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijrobp.2015.12.368","article-title":"Impact of spot size and beam-shaping devices on the treatment plan quality for pencil beam scanning proton therapy","volume":"95","author":"Moteabbed","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.meddos.2025.01.006_bib0032","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1002\/mp.13809","article-title":"Technical Note: ttreatment planning system (TPS) approximations matter \u2014 Comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC)","volume":"46","author":"Liu","year":"2019","journal-title":"Med Phys"},{"key":"10.1016\/j.meddos.2025.01.006_bib0033","doi-asserted-by":"crossref","DOI":"10.21037\/jxym.2018.11.04","article-title":"Interplay effect in lung cancer proton therapy","volume":"3","author":"Phua","year":"2018","journal-title":"J Xiangya Med"},{"issue":"5","key":"10.1016\/j.meddos.2025.01.006_bib0034","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1118\/1.4916662","article-title":"Motion mitigation for lung cancer patients treated with active scanning proton therapy","volume":"42","author":"Grassberger","year":"2015","journal-title":"Med Phys"},{"issue":"6","key":"10.1016\/j.meddos.2025.01.006_bib0035","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/mp.17082","article-title":"Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: interplay effects and mitigations","volume":"51","author":"Liu","year":"2024","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.meddos.2025.01.006_bib0036","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ijrobp.2015.11.002","article-title":"Exploratory study of 4D versus 3D robust optimization in intensity modulated proton therapy for lung cancer","volume":"95","author":"Liu","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394725000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394725000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T10:22:50Z","timestamp":1753957370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394725000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"alternative-id":["S0958394725000081"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2025.01.006","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing proton plans with 3 different beam lines vs photon plans for early-stage lung cancer","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Association of Medical Dosimetrists.","name":"copyright","label":"Copyright"}]}}